PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2014

Inhibition of gene expression of carnitine palmitoyltransferase I and heart fatty acid binding protein in cyclophosphamide and ifosfamide-induced acute cardiotoxic rat models.

Rat / Chemical/toxin

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 24469765 ↗2014Reported benefit

Inhibition of gene expression of carnitine palmitoyltransferase I and heart fatty acid binding protein in cyclophosphamide and ifosfamide-induced acute cardiotoxic rat models.

RatChemical/toxinWistar albinoMalen = Six treatment groups; number of animals per group not statedIntraperitoneal injection200 mg/kg per dayGiven for 5 days before and 5 days after a single cyclophosphamide dose, or for…

Model: Acute cardiotoxicity induced by a single intraperitoneal dose of cyclophosphamide 200 mg/kg or by ifosfamide 50 mg/kg per day intraperitoneally for 5 days

Cyclophosphamide and ifosfamide reduced cardiac heart fatty acid binding protein and carnitine palmitoyltransferase I expression and raised lactate dehydrogenase, creatine kinase MB and malonyl-CoA with histopathological lesions; carnitine supplementation reversed all biochemical, histopathological…

Extraction: extract · Supplied extraction confidence: 0.8. Machine-extracted fields require source verification.